The WOE supports a nonlinear, threshold dose-response for alpha-HCH carcinogenicity.
Alpha-HCH causes liver tumors in rats and mice through an MOA involving mitogenesis.
We establish a nonlinear RfD for alpha-HCH of 0.002 mg/kg-day that is protective of chronic exposure to humans.
Given its regulatory focus, agencies should review the evidence that alpha-HCH acts as a threshold based toxicant.